// App-Quantinova.ai

e15004 : Thyroid dysfunction in disguise and treatment-related fatigue in the spotlight among metastatic colorectal cancer patients receiving regorafenib: Implications for clinical management.

Researchers

Presenter

  • Laura Orgiano

Principal Investigators

  • Fabiana Pani

  • Valeria Pusceddu

  • Giorgio Astara

  • Clelia Madeddu

  • Elena Massa

  • Alessio Cubeddu

  • Laura Demurtas

  • Alessandra Dessi

  • Eleonora Lai

  • Roberta Mascia

  • Simona Tolu

  • Grazia Pusole

  • Marco Puzzoni

  • Francesco Boi

  • Stefano Mariotti

  • Mario Scartozzi

Medical Centers

  • AOU Cagliari, Department of Medical Sciences, Monserrato, Italy

  • Endocrinology and Diabetes Unit, Department of Medical SciencesUniversity of Cagliari, Cagliari, Italy

  • Department of Medical Oncology, Hospital-University, Cagliari, Italy

  • AOU Cagliari, Department of Medical Oncology, Cagliari, Italy

  • AOU Cagliari, Department of Medical Oncology, Cagliari, Italy

  • Medical Oncology, University of Cagliari, Cagliari, Italy

  • AOU Cagliari, Department of Medical Sciences, Monserrato, Italy

  • Endocrinology, Department of Medical Sciences and Azienda, Ospedaliero-Universitaria di Cagliari, University of Cagliari, Cagliari, Italy

  • University Hospital of Cagliari, Cagliari, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Colorectal Cancer

  • Hypothyroidism

  • Solid malignancies

Biomarkers

  • Human albumin

  • Lactate dehydrogenase

Drug/Treatment

  • Regorafenib

  • Ergocalciferol

Outcome

  • Unknown

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved